The proliferation and differentiation of pre-osteoblastic MC3T3-E1 cells from Vietnamese drug formulations

A public heath problem, osteoporosis, is recognized as the prevalent disease, and mainly causes for impairment and loss mass of bone. It closely related the balance between bone formation by osteoblasts and resorption by osteoclasts during the remodeling cycle of bone. Hence, pharmaceutical therapies are looking for the potential agents to stimulate osteoblastic bone formation, as well as inhibit osteoclastic processes